Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 818912, 7 pages
http://dx.doi.org/10.1155/2013/818912
Review Article

Potential Mechanisms for Racial and Ethnic Differences in Antimüllerian Hormone and Ovarian Reserve

Genesis Fertility & Reproductive Medicine, Division of Reproductive Endocrinology and Infertility, Maimonides Medical Center, 1355 84th Street, Brooklyn, NY 11228, USA

Received 11 June 2013; Revised 21 October 2013; Accepted 21 October 2013

Academic Editor: Petra Stute

Copyright © 2013 Reshef Tal and David B. Seifer. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Wu, P. Mendola, and G. M. Buck, “Ethnic differences in the presence of secondary sex characteristics and menarche among US girls: the third National Health and Nutrition Examination Survey, 1988–1994,” Pediatrics, vol. 110, no. 4, pp. 752–757, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. E. Herman-Giddens, E. J. Slora, R. C. Wasserman et al., “Secondary sexual characteristics and menses in young girls seen in office practice: a study from the pediatric research in office settings network,” Pediatrics, vol. 99, no. 4, pp. 505–512, 1997. View at Google Scholar · View at Scopus
  3. J. C. Abma, A. Chandra, W. D. Mosher, L. S. Peterson, and L. J. Piccinino, “Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth,” Vital and Health Statistics, vol. 23, no. 19, pp. 1–114, 1997. View at Google Scholar · View at Scopus
  4. E. H. Stephen and A. Chandra, “Declining estimates of infertility in the United States: 1982–2002,” Fertility and Sterility, vol. 86, no. 3, pp. 516–523, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. F. I. Sharara and H. D. McClamrock, “Differences in in vitro fertilization (IVF) outcome between white and black women in an inner-city, university-based IVF program,” Fertility and Sterility, vol. 73, no. 6, pp. 1170–1173, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Y. Fujimoto, B. Luke, M. B. Brown et al., “Racial and ethnic disparities in assisted reproductive technology outcomes in the United States,” Fertility and Sterility, vol. 93, no. 2, pp. 382–390, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. D. B. Seifer, R. Zackula, and D. A. Grainger, “Trends of racial disparities in assisted reproductive technology outcomes in black women compared with white women: society for Assisted Reproductive Technology 1999 and 2000 vs. 2004–2006,” Fertility and Sterility, vol. 93, no. 2, pp. 626–635, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. D. B. Seifer, L. M. Frazier, and D. A. Grainger, “Disparity in assisted reproductive technologies outcomes in black women compared with white women,” Fertility and Sterility, vol. 90, no. 5, pp. 1701–1710, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. V. L. Baker, B. Luke, M. B. Brown et al., “Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System,” Fertility and Sterility, vol. 94, no. 4, pp. 1410–1416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Jain and M. D. Hornstein, “Disparities in access to infertility services in a state with mandated insurance coverage,” Fertility and Sterility, vol. 84, no. 1, pp. 221–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. S. A. Missmer, D. B. Seifer, and T. Jain, “Cultural factors contributing to health care disparities among patients with infertility in Midwestern United States,” Fertility and Sterility, vol. 95, no. 6, pp. 1943–1949, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. L. Stanford, P. Hartge, L. A. Brinton, R. N. Hoover, and R. Brookmeyer, “Factors influencing the age at natural menopause,” Journal of Chronic Diseases, vol. 40, no. 11, pp. 995–1002, 1987. View at Google Scholar · View at Scopus
  13. J. T. Bromberger, K. A. Matthews, L. H. Kuller, R. R. Wing, E. N. Meilahn, and P. Plantinga, “Prospective study of the determinants of age at menopause,” American Journal of Epidemiology, vol. 145, no. 2, pp. 124–133, 1997. View at Google Scholar · View at Scopus
  14. B. MacMahon and J. Worcester, “Age at menopause. United States 1960–1962,” Vital and Health Statistics, vol. 11, no. 19, pp. 1–20, 1966. View at Google Scholar · View at Scopus
  15. J. F. Randolph Jr., M. Sowers, E. B. Gold et al., “Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 4, pp. 1516–1522, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. E. B. Gold, B. Sternfeld, J. L. Kelsey et al., “Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age,” American Journal of Epidemiology, vol. 152, no. 5, pp. 463–473, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. E. W. Freeman, M. D. Sammel, C. R. Gracia et al., “Follicular phase hormone levels and menstrual bleeding status in the approach to menopause,” Fertility and Sterility, vol. 83, no. 2, pp. 383–392, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. J. L. Luborsky, P. Meyer, M. F. Sowers, E. B. Gold, and N. Santoro, “Premature menopause in a multi-ethnic population study of the menopause transition,” Human Reproduction, vol. 18, no. 1, pp. 199–206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. D. B. Seifer and D. T. MacLaughlin, “Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance,” Fertility and Sterility, vol. 88, no. 3, pp. 539–546, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. D. B. Seifer, D. T. MacLaughlin, B. P. Christian, B. Feng, and R. M. Shelden, “Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles,” Fertility and Sterility, vol. 77, no. 3, pp. 468–471, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. I. A. J. van Rooij, I. den Tonkelaar, F. J. M. Broekmans et al., “Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition,” Menopause, vol. 11, no. 6, pp. 601–606, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. A. de Vet, J. S. E. Laven, F. H. de Jong, A. P. N. Themmen, and B. C. J. M. Fauser, “Antimüllerian hormone serum levels: a putative marker for ovarian aging,” Fertility and Sterility, vol. 77, no. 2, pp. 357–362, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. A. la Marca, G. Stabile, A. Carducci Artenisio, and A. Volpe, “Serum anti-Mullerian hormone throughout the human menstrual cycle,” Human Reproduction, vol. 21, no. 12, pp. 3103–3107, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. A. la Marca, S. Giulini, R. Orvieto, V. de Leo, and A. Volpe, “Anti-Mullerian hormone concentrations in maternal serum during pregnancy,” Human Reproduction, vol. 20, no. 6, pp. 1569–1572, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Somunkiran, T. Yavuz, O. Yucel, and I. Ozdemir, “Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 134, no. 2, pp. 196–201, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. D. B. Seifer, E. T. Golub, G. Lambert-Messerlian et al., “Variations in serum müllerian inhibiting substance between white, black, and Hispanic women,” Fertility and Sterility, vol. 92, no. 5, pp. 1674–1678, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Gleicher, A. Kim, A. Weghofer, and D. H. Barad, “Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene,” Reproductive Biology and Endocrinology, vol. 10, article 77, 2012. View at Publisher · View at Google Scholar
  28. O. Rustamov, A. Smith, S. A. Roberts et al., “Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability,” Human Reproduction, vol. 27, no. 10, pp. 3085–3091, 2012. View at Publisher · View at Google Scholar
  29. O. Rustamov, P. W. Pemberton, S. A. Roberts et al., “The reproducibility of serum anti-Müllerian hormone in subfertile women: within and between patient variability,” Fertility and Sterility, vol. 95, no. 3, pp. 1185–1187, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Block, “Quantitative morphological investigations of the follicular system in women; variations at different ages,” Acta Anatomica, vol. 14, no. 1-2, pp. 108–123, 1952. View at Google Scholar · View at Scopus
  31. E. Block, “A quantitative morphological investigation of the follicular system in newborn female infants,” Acta Anatomica, vol. 17, no. 3, pp. 201–206, 1953. View at Google Scholar · View at Scopus
  32. E. A. McGee and A. J. W. Hsueh, “Initial and cyclic recruitment of ovarian follicles,” Endocrine Reviews, vol. 21, no. 2, pp. 200–214, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Snieder, A. J. Macgregor, and T. D. Spector, “Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 6, pp. 1875–1880, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. J. P. de Bruin, H. Bovenhuis, P. A. H. Van Noord et al., “The role of genetic factors in age at natural menopause,” Human Reproduction, vol. 16, no. 9, pp. 2014–2018, 2001. View at Google Scholar · View at Scopus
  35. J. M. Meyer, L. J. Eaves, A. C. Heath, and N. G. Martin, “Estimating genetic influences on the age-at-menarche: a survival analysis approach,” American Journal of Medical Genetics, vol. 39, no. 2, pp. 148–154, 1991. View at Google Scholar · View at Scopus
  36. M. P. Rosen, E. B. Johnstone, S. J. Gillham et al., “Is antral follicle count a genetic trait?” Menopause, vol. 17, no. 1, pp. 109–113, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. S. M. Schuh-Huerta, N. A. Johnson, M. P. Rosen, B. Sternfeld, M. I. Cedars, and R. A. Reijo Pera, “Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women,” Human Reproduction, vol. 27, no. 2, pp. 594–608, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Ben-Shlomo, U. A. Vitt, and A. J. W. Hsueh, “Perspective: the ovarian kaleidoscope database-II. Functional genomic analysis of an organ-specific database,” Endocrinology, vol. 143, no. 6, pp. 2041–2044, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. S. M. Schuh-Huerta, N. A. Johnson, M. P. Rosen, B. Sternfeld, M. I. Cedars, and R. A. Reijo Pera, “Genetic markers of ovarian follicle number and menopause in women of multiple ethnicities,” Human Genetics, vol. 131, no. 11, pp. 1709–1724, 2012. View at Publisher · View at Google Scholar
  40. N. Gleicher, A. Weghofer, K. Oktay, and D. Barad, “Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve,” Reproductive Biomedicine Online, vol. 19, no. 3, pp. 385–390, 2009. View at Google Scholar · View at Scopus
  41. N. Gleicher, A. Weghofer, and D. H. Barad, “Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian ageing,” Reproductive BioMedicine Online, vol. 20, no. 6, pp. 768–775, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Gleicher, A. Weghofer, A. Kim, and D. H. Barad, “The impact in older women of ovarian FMR1 genotypes and sub-genotypes on ovarian reserve,” PLoS ONE, vol. 7, no. 3, Article ID e33638, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Gleicher, A. Weghofer, and D. H. Barad, “Effects of race/ethnicity on triple CGG counts in the FMR1 gene in infertile women and egg donors,” Reproductive BioMedicine Online, vol. 20, no. 4, pp. 485–491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. S. A. Narod, “BRCA mutations in the management of breast cancer: the state of the art,” Nature Reviews Clinical Oncology, vol. 7, no. 12, pp. 702–707, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. N. D. Kauff, J. M. Satagopan, M. E. Robson et al., “Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation,” The New England Journal of Medicine, vol. 346, no. 21, pp. 1609–1615, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Oktay, J. Y. Kim, D. Barad, and S. N. Babayev, “Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks,” Journal of Clinical Oncology, vol. 28, no. 2, pp. 240–244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. I. Rzepka-Górska, B. Tarnowski, A. Chudecka-Głaz, B. Górski, D. Zielińska, and A. Tołoczko-Grabarek, “Premature menopause in patients with BRCA1 gene mutation,” Breast Cancer Research and Treatment, vol. 100, no. 1, pp. 59–63, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Titus, F. Li, R. Stobezki et al., “Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans,” Science Translational Medicine, vol. 5, Article ID 172ra121, 2013. View at Google Scholar
  49. E. M. John, A. Miron, G. Gong et al., “Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups,” Journal of the American Medical Association, vol. 298, no. 24, pp. 2869–2876, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. B. Newman, H. Mu, L. M. Butler, R. C. Millikan, P. G. Moorman, and M.-C. King, “Frequency of breast cancer attributable to BRCA1 in a population-based series of American women,” Journal of the American Medical Association, vol. 279, no. 12, pp. 915–921, 1998. View at Publisher · View at Google Scholar · View at Scopus
  51. K. E. Malone, J. R. Daling, D. R. Doody et al., “Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years,” Cancer Research, vol. 66, no. 16, pp. 8297–8308, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. K. M. Flegal, M. D. Carroll, C. L. Ogden, and L. R. Curtin, “Prevalence and trends in obesity among US adults, 1999–2008,” Journal of the American Medical Association, vol. 303, no. 3, pp. 235–241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. M. S. Kupka, C. Gnoth, K. Buehler, W. Dahncke, and J.-S. Kruessel, “Impact of female and male obesity on IVF/ICSI: Results of 700,000 ART-cycles in Germany,” Gynecological Endocrinology, vol. 27, no. 3, pp. 144–149, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. D. Zhang, Y. Zhu, H. Gao et al., “Overweight and obesity negatively affect the outcomes of ovarian stimulation and invitro fertilisation: a cohort study of 2628 Chinese women,” Gynecological Endocrinology, vol. 26, no. 5, pp. 325–332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Maheshwari, L. Stofberg, and S. Bhattacharya, “Effect of overweight and obesity on assisted reproductive technology—a systematic review,” Human Reproduction Update, vol. 13, no. 5, pp. 433–444, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Dechaud, T. Anahory, L. Reyftmann, V. Loup, S. Hamamah, and B. Hedon, “Obesity does not adversely affect results in patients who are undergoing in vitro fertilization and embryo transfer,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 127, no. 1, pp. 88–93, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. E. W. Freeman, C. R. Gracia, M. D. Sammel, H. Lin, L. C.-L. Lim, and J. F. Strauss III, “Association of anti-mullerian hormone levels with obesity in late reproductive-age women,” Fertility and Sterility, vol. 87, no. 1, pp. 101–106, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Z. Steiner, F. Z. Stanczyk, S. Patel, and A. Edelman, “Antimullerian hormone and obesity: insights in oral contraceptive users,” Contraception, vol. 81, no. 3, pp. 245–248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. E. Buyuk, D. B. Seifer, E. Illions, R. V. Grazi, and H. Lieman, “Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve,” Fertility and Sterility, vol. 95, no. 7, pp. 2364–2368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. L. L.-Y. Wu, K. R. Dunning, X. Yang et al., “High-fat diet causes lipotoxicity responses in cumulus-oocyte complexes and decreased fertilization rates,” Endocrinology, vol. 151, no. 11, pp. 5438–5445, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. H. I. Su, M. D. Sammel, E. W. Freeman, H. Lin, T. Deblasis, and C. R. Gracia, “Body size affects measures of ovarian reserve in late reproductive age women,” Menopause, vol. 15, no. 5, pp. 857–861, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Kadowaki and T. Yamauchi, “Adiponectin and adiponectin receptors,” Endocrine Reviews, vol. 26, no. 3, pp. 439–451, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Ledoux, D. B. Campos, F. L. Lopes, M. Dobias-Goff, M.-F. Palin, and B. D. Murphy, “Adiponectin induces periovulatory changes in ovarian follicular cells,” Endocrinology, vol. 147, no. 11, pp. 5178–5186, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. Z. Merhi, E. Buyuk, D. S. Berger et al., “Leptin suppresses anti-Mullerian hormone gene expression through the JAK2/STAT3 pathway in luteinized granulosa cells of women undergoing IVF,” Human Reproduction, vol. 28, no. 6, pp. 1661–1669, 2013. View at Publisher · View at Google Scholar
  65. Z. O. Merhi, D. B. Seifer, J. Weedon et al., “Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study,” Fertility and Sterility, vol. 98, pp. 228–234, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. N. A. Dennis, L. A. Houghton, G. T. Jones, A. M. van Rij, K. Morgan, and I. S. McLennan, “The level of serum anti-mullerian hormone correlates with vitamin d status in men and women but not in boys,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, pp. 2450–2455, 2012. View at Publisher · View at Google Scholar
  67. P. Coney, L. M. Demers, W. C. Dodson, A. R. Kunselman, G. Ladson, and R. S. Legro, “Determination of vitamin D in relation to body mass index and race in a defined population of black and white women,” International Journal of Gynecology & Obstetrics, vol. 119, no. 1, pp. 21–25, 2012. View at Publisher · View at Google Scholar
  68. P. J. Malloy, L. Peng, J. Wang, and D. Feldman, “Interaction of the vitamin D receptor with a vitamin D response element in the müllerian-inhibiting substance (MIS) promoter: Regulation of MIS expression by calcitriol in prostate cancer cells,” Endocrinology, vol. 150, no. 4, pp. 1580–1587, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. O. M. Adeyemi, D. Agniel, A. L. French et al., “Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States,” Journal of Acquired Immune Deficiency Syndromes, vol. 57, no. 3, pp. 197–204, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. M. R. Sowers and M. T. La Pietra, “Menopause: its epidemiology and potential association with chronic diseases,” Epidemiologic Reviews, vol. 17, no. 2, pp. 287–302, 1995. View at Google Scholar · View at Scopus
  71. M. R. Sowers, D. McConnell, M. Yosef, M. L. Jannausch, S. D. Harlow, and J. F. Randolph Jr., “Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period,” Annals of the New York Academy of Sciences, vol. 1204, pp. 95–103, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. B. J. Plante, G. S. Cooper, D. D. Baird, and A. Z. Steiner, “The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 years,” Menopause, vol. 17, no. 3, pp. 571–576, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. E. B. Gold, A. Colvin, N. Avis et al., “Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation,” American Journal of Public Health, vol. 96, no. 7, pp. 1226–1235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. D. R. Mattison and S. S. Thorgeirsson, “Smoking and industrial pollution, and their effects on menopause and ovarian cancer,” The Lancet, vol. 1, no. 8057, pp. 187–188, 1978. View at Google Scholar · View at Scopus
  75. T. Paszkowski, R. N. Clarke, and M. D. Hornstein, “Smoking induces oxidative stress inside the Graafian follicle,” Human Reproduction, vol. 17, no. 4, pp. 921–925, 2002. View at Google Scholar · View at Scopus
  76. K. E. Valdez and B. K. Petroff, “Potential roles of the aryl hydrocarbon receptor in female reproductive senescence,” Reproductive Biology, vol. 4, no. 3, pp. 243–258, 2004. View at Google Scholar · View at Scopus
  77. B. J. Gulyas and D. R. Mattison, “Degeneration of mouse oocytes in response to polycyclic aromatic hydrocarbons,” Anatomical Record, vol. 193, no. 4, pp. 863–882, 1979. View at Google Scholar · View at Scopus
  78. D. R. Mattison and S. S. Thorgeirsson, “Ovarian aryl hydrocarbon hydroxylase activity and primordial oocyte toxicity of polycyclic aromatic hydrocarbons in mice,” Cancer Research, vol. 39, no. 9, pp. 3471–3475, 1979. View at Google Scholar · View at Scopus
  79. M. T. Zenzes, L. A. Puy, and R. Bielecki, “Immunodetection of cotinine protein in granulosa-lutein cells of women exposed to cigarette smoke,” Fertility and Sterility, vol. 68, no. 1, pp. 76–82, 1997. View at Publisher · View at Google Scholar · View at Scopus
  80. M. T. Zenzes, S. Krishnan, B. Krishnan, H. Zhang, and R. F. Casper, “Cadmium accumulation in follicular fluid of women in in vitro fertilization-embryo transfer is higher in smokers,” Fertility and Sterility, vol. 64, no. 3, pp. 599–603, 1995. View at Google Scholar · View at Scopus
  81. T. Weiss and A. Eckert, “Cotinine levels in follicular fluid and serum of IVF patients: effect on granulose-luteal cell function in vitro,” Human Reproduction, vol. 4, no. 5, pp. 482–485, 1989. View at Google Scholar · View at Scopus
  82. R. Bordel, M. W. Laschke, M. D. Menger, and B. Vollmar, “Nicotine does not affect vascularization but inhibits growth of freely transplanted ovarian follicles by inducing granulosa cell apoptosis,” Human Reproduction, vol. 21, no. 3, pp. 610–617, 2006. View at Publisher · View at Google Scholar · View at Scopus